Reimbursed
Patient Access
We help biotech and pharmaceutical companies navigating pricing, reimbursement, and early access pathways to bring innovative therapies to BeNeLux patients in a sustainable way.
100%
Executional Excellence
+25 yrs
Experience
120+
Successful Submissions
3 Countries
BeNeLux Client Partnerships
How We Support Patient Access
Our expertise consists in navigating Pricing & Reimbursement, Guided Patient Access and Real-World Data
We demonstrate strategic engagement and executional excellence
with deep respect for the patient’s voice.
Bringing innovative medicines of pharmaceutical and biotech companies to patients, sustainably and meaningfully
Cardiology
Nephrology
Haematology
Oncology
Respiratory
Neurology
Orphan Diseases
Dermatology
Therapeutic Domains
We bring extensive experience across a broad range of therapeutic domains
Value Proposition
Crafting a compelling value story and gathering necessary clinical and economic evidence.
02
Landscape Assessment
An in-depth analysis of the current landscape, unmet needs, and payer perceptions.
01
03
Strategy Development
Defining the optimal pricing, access strategy and innovative contracting.
Strategy Development
Defining the optimal pricing, contracting, and access strategy for each target market.
03
04
Execution & Launch
Following up on addressing clinical and budgetary uncertainties to maintain patient access.
Our Methodology
Integrated Market Access Solutions
A systematic approach ensuring no critical milestone is overlooked, from early-stage development to post-launch optimisation.
Ready to optimise your access strategy?
Contact us to discuss how we can support your patient access objectives








